Normethandrone has not been assigned an INN or other formal name designations. It is also known as methylestrenolone, methylnortestosterone, normethandrolone, and normethisterone.
Brand names of normethandrone include Batynid, Ginecosid, Ginecoside, Gynomin, Lutenin, Matronal, Mediol, Metalutin, Methalutin, Orgasteron, Orosteron, and Renodiol.
Normethandrone (Orgasteron; Metalutin; Methalutin) is a progestin and androgen/anabolic steroid agent which is used in combination with an estrogen in the treatment of menstruation disorders in women. Normethandrone is a modified form of nandrolone. It differs by the addition of a methyl group at carbon 17-alpha to protect the hormone during oral administration. Normethandrone is aromatized by the body, and converts to a synthetic estrogen with a high level of biological activity (17alpha-methyl-estradiol). Orgasteron has been used as progestational agent and as an androgen. Normethandrone is available in combination with methylestradiol or estradiol valerate in a few countries, including Brazil, Indonesia, and Venezuela. This is a controlled substance (anabolic steroid): 21 CFR, 1308.13, as defined in 1300.01. Normethandrone was first described in 1954. Shortly after, it was developed into a medicine by Organon (now Merck/MSD), which introduced it under the Orgasterone brand name in Belgium and Switzerland, and as Orgasteron in the Netherlands. This steroid had also been sold by other manufacturers in various parts of Europe as Methalutin, Lutenin, and Matdonal. Although a simple oral methylated nandrolone, with strong properties as an anabolic steroid, Normethandrone exhibits such strong progestational activity that it was marketed as an oral progestin. Its anabolic effects were more looked at as secondary applications for the drug, and accounted for very little medical interest.
Normethandrolone is a potent oral anabolic steroid derived from nandrolone. Also called methylnandrolone or methylnortestosterone, normethandrolone can crudely be looked at as the "methyltestosterone of nandrolone." It differs from its parent hormone nandrolone only by the addition of c-17 alpha methyl group, the same alteration that creates methyltestosterone from testosterone. This, of course, was added to make oral dosing viable. Animal studies looking at the oral potency of this steroid rate it to be roughly 3-6 times more anabolic than methyltestosterone, while possessing only roughly 10-25% more androgenicity. The overall anabolic-androgenic ratio of this steroid falls somewhere between 3:1 and 5.5:1. Although it is effective orally, normethandrolone is not the, most ideal steroid for bodybuilders and athletes, at least where lean mass or sports performance are concerned (something for which nandrolone is highly favored). In this case methylation has amplified the estrogenic and progestational activity of the steroid considerably, which means that muscle gains are likely to be accompanied by considerable water and fat retention.
Orgasteron, a.k.a. normethandrolone, is essentially an oral version of the anabolic steroid nandrolone. Although no longer commercially available as a prescription medication, Orgasteron was produced in 2.5, 5, and 10 mg tablets. Reportedly, underground lab versions of this compound still exist. Orgasteron is most often administered at the start of bulking cycles in 10-30 mg/day for 6-8 weeks. Taking Orgasteron on an empty stomach, to prevent it from competing with nutrients, promotes optimal absorption. Traditionally, nandrolone is considered a very adaptable compound that can be easily incorporated into all types of cycles. However, Orgasteron is an exception, compliments of its c-17aa addition, which enhances both its anabolic and unfortunately androgenic properties as well. Due to its magnified 110-125 androgenic range, Orgasteron aromatizes more like a testosterone than a nandrolone, which also prevents it from being a good choice for cutting cycles. More popularly used within mass building cycles, its typically stacked with testosterone.
a progestin and androgen/anabolic steroid medication which is used in combination with an estrogen in the treatment of amenorrhea and menopausal symptoms in women. It is taken by mouth. Side effects of normethandrone include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It can also cause liver damage. Normethandrone was introduced for medical use by 1957. It is available only in a few countries, including Brazil, Indonesia, and Venezuela, and is available only in combination with methylestradiol or estradiol valerate. The combination of normethandrone and methylestradiol was introduced by at least 1966. Normethandrone has been used successfully to inhibit libido in men with sexual deviance.
|Steroids | Link to this page